ResearcherAristotle University of ThessalonikiActive in the last 2 years
Dimitrios E. Giakoustidis
Matched on ORCID iD 0000-0002-6023-4744; OpenAlex author ID A5031417617. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 31
2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 4
- Futility in adenosquamous pancreatic cancer. Co-author DOI 10.1186/s12957-026-04351-1↗
- The Role of Nanoparticles in Therapy of Real-World Patients with Pancreatic Cancer: A Scoping Review. Co-author DOI 10.3390/cancers17101726↗
- Contemporary management of borderline resectable pancreatic ductal adenocarcinoma. Last author DOI 10.14701/ahbps.2019.23.2.97↗
- Identifying the role of neutrophil-to-lymphocyte ratio and platelets-to-lymphocyte ratio as prognostic markers in patients undergoing resection of pancreatic d… Co-author DOI 10.14701/ahbps.2018.22.3.197↗
Closest collaborators
The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Alexandros E. Giakoustidis · 3 shared papers, 2018–2025 · strength 0.44
- Paper The Role of Nanoparticles in Therapy of Real-World Patients with Pancreatic Cancer: A Scoping Review. DOI 10.3390/cancers17101726↗
- Paper Contemporary management of borderline resectable pancreatic ductal adenocarcinoma. DOI 10.14701/ahbps.2019.23.2.97↗
- Paper Identifying the role of neutrophil-to-lymphocyte ratio and platelets-to-lymphocyte ratio as prognostic markers in patie… DOI 10.14701/ahbps.2018.22.3.197↗
- Theodora Papamitsou · 1 shared paper, 2025 · strength 0.23
- Ioannis K. Konstantinidis · 1 shared paper, 2025 · strength 0.23
- Sophia Tsokkou · 1 shared paper, 2025 · strength 0.23
- Cristina Vallejo Bernad · 1 shared paper, 2026 · strength 0.18
- Julie Navez · 1 shared paper, 2026 · strength 0.18
- Bodil Andersson · 1 shared paper, 2026 · strength 0.18
- Bergþór Björnsson · 1 shared paper, 2026 · strength 0.18
- Santiago Sánchez-Cabús · 1 shared paper, 2026 · strength 0.18
- Sebastian Manuel Staubli · 1 shared paper, 2026 · strength 0.18
- Gennaro Nappo · 1 shared paper, 2026 · strength 0.18
- Maria João Amaral · 1 shared paper, 2026 · strength 0.18
- Anita Balakrishnan · 1 shared paper, 2026 · strength 0.18
- Alessandro Zerbi · 1 shared paper, 2026 · strength 0.18
- Pietro Addeo Md · 1 shared paper, 2026 · strength 0.18
- Philippe Bachellier · 1 shared paper, 2026 · strength 0.18
- Dimitrios Lytras · 1 shared paper, 2026 · strength 0.18
- José Manuel Ramia · 1 shared paper, 2026 · strength 0.18
- Sanjay Pandanaboyana · 1 shared paper, 2026 · strength 0.18
- Gerardo Blanco‐Fernández · 1 shared paper, 2026 · strength 0.18
- Mario Serradilla-Martín · 1 shared paper, 2026 · strength 0.18
- Jakob Kirkegård · 1 shared paper, 2026 · strength 0.18
- Juli Busquets · 1 shared paper, 2026 · strength 0.18
- Ahmad Mahamid · 1 shared paper, 2026 · strength 0.18
- Elizabeth Pando Rau · 1 shared paper, 2026 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.